Reprogramming Metabolism and Immunity: Nanotechnology’s Promise for Hepatocellular Carcinoma Precision Therapy
International Journal of Nanomedicine · 2026-06 · Volume 21 · 1-26
DOI: 10.2147/ijn.s587514 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-06. Verfasst von Mingrong Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Nanxiang Branch of Ruijin Hospital, Shanghai, 201802, People's Republic of China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Precision Medicine, Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Nanxiang Branch of Ruijin Hospital, Shanghai, 201802, People's Republic of China.
- Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, People's Republic of China.
Zitieren
APA
Cheng, M., Ni, Y., Zhang, W., & Wu, Q. (2026). Reprogramming Metabolism and Immunity: Nanotechnology’s Promise for Hepatocellular Carcinoma Precision Therapy. International Journal of Nanomedicine, Volume 21, 1-26. https://doi.org/10.2147/ijn.s587514
Vancouver
Cheng M, Ni Y, Zhang W, Wu Q. Reprogramming Metabolism and Immunity: Nanotechnology’s Promise for Hepatocellular Carcinoma Precision Therapy. International Journal of Nanomedicine. 2026;Volume 21:1-26. doi:10.2147/ijn.s587514
BibTeX
@article{Cheng2026,
author = {Cheng, Mingrong and Ni, Yucheng and Zhang, Wei and Wu, Qinghua},
title = {Reprogramming Metabolism and Immunity: Nanotechnology’s Promise for Hepatocellular Carcinoma Precision Therapy},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--26},
doi = {10.2147/ijn.s587514}
}
EUVIMED